Fig. 4From: Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancerDistribution of the methylation status in tumor (T), tumor-adjacent (A) and tumor-distant (D) tissues as well as normal breast tissues obtained from women undergoing reduction mammoplasty (N). All patients have been included. Straight line: median, dashed line: arithmetic meanBack to article page